GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Total Long-Term Liabilities

Theratechnologies (TSX:TH) Total Long-Term Liabilities : C$65.4 Mil (As of Feb. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Theratechnologies's Total Long-Term Liabilities for the quarter that ended in Feb. 2025 was C$65.4 Mil.

Theratechnologies Total Long-Term Liabilities Historical Data

The historical data trend for Theratechnologies's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Total Long-Term Liabilities Chart

Theratechnologies Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.90 70.85 2.09 70.38 58.34

Theratechnologies Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.61 56.64 49.83 58.34 65.45

Theratechnologies Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Theratechnologies Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Total Long-Term Liabilities
Comparable Companies
TSX:EPRX TSX:MSCL NEOE:CYBN TSXV:ARCH TSX:MDNA XCNQ:GLAB TSXV:COV XCNQ:METX TSX:SVA NEOE:ONCO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
THTX:USA TQ80:Germany
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Executives
Dale Weil Director
Joseph Arena Director
Philippe Dubuc Senior Officer
Gérald A. Lacoste Director
Paul Lévesque Senior Officer
Andrew Molson Director
Dawn Svoronos Director
John Leasure Senior Officer
Jocelyn Lafond Senior Officer
Alain Trudeau Director
Sheila Frame Director
Gary Peter Littlejohn Director
Marie-noël Colussi Senior Officer
Jovan Antunovic Senior Officer
Christian Marsolais Senior Officer